Background and Objective: Candida auris (CA) is an emerging fungus identified in 2009 that, given its worldwide spread and unique characteristics, has been classified as an urgent global health threat: it resists to common antifungal drugs and decontamination procedures; identification requires specific tools; transmissibility and mortality are high in healthcare settings, especially for patients in intensive care units. Infection and colonization can be long-lasting, leading to problems in isolation procedures and the risk of outbreaks. This study aims to evaluate publication and citation related metrics, identify major Keywords and topics, and assess geographic distribution of published articles. Methods: A list of all publications containing "Candida Auris" in all fields was extracted from Web Of Science on date 2022/11/18. Bibliometric analysis was conducted using the bibliometrix and biblioshiny packages on RStudio. Results: Total publications (TP) were 1234 with an annual growth rate of 51.58%. Only 12.7% of 4859 contributing authors published ≥ 3 articles about CA. Total citations were 26901, with an average of 21.8 citations per paper. The core sources are 9 out of 317, according to Bradfords law. In only 42 countries where CA was identified, articles on the topic were published (89%). The origin of TP is heterogeneous: 31% Europe, 29% North-America, 25% Asia, 8% South-America, 4% Africa, 3% Oceania. Trending topics about CA include epidemiology, identification and resistance. Conclusions: Our analysis shows a growing interest in scientific literature on the topic of CA, led by Europe. In some countries where CA has been identified, no papers have been published. Despite the multidrug-resistance of CA, the topic of therapy is not much debated. Our findings highlight the need to increase focus on CA in order to promote health systems’ preparedness and to properly address the spread of this worrisome pathogen.